RecruitingNCT07034274
National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical
Sponsor
Dacima Consulting
Enrollment
5,000 participants
Start Date
Jun 9, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
A non-interventional, national longitudinal multicenter study of CV secondary prevention in Tunisia
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria4
- Age > 18 years and < 80 years
- Patients who have been hospitalized for at least one acute coronary event with coronary revascularization, either percutaneous or surgical by coronary artery bypass grafting, or who have confirmed coronary artery disease requiring optimal medical treatment for more than 6 months
- Coronary event happening in 2024
- Informed, read and signed consent
Exclusion Criteria1
- Familial hypercholesterolemia
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07034274
Related Trials
Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients
NCT075428601 location
Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial
NCT075146111 location
The Southern-Norway Post-Stroke Atrial Fibrillation Study
NCT074077901 location
SmartWatch-driven AF Detection in Stroke Patients
NCT0683257913 locations
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
NCT0664924046 locations